Corpus Intelligence IC Memo — BLACKWELL REGIONAL HOSPITAL 2026-04-26 09:35 UTC
IC Memo — BLACKWELL REGIONAL HOSPITAL
Investment Committee Memorandum | OK | 34 beds | Grade D | EBITDA uplift $588K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BLACKWELL REGIONAL HOSPITAL

CCN 370030 | KAY, OK | 34 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BLACKWELL REGIONAL HOSPITAL is a 34-bed rural/critical access in KAY, OK with $7.9M in net patient revenue and a -33.7% operating margin. The hospital serves a payer mix of 51.5% Medicare, 12.0% Medicaid, and 36.4% commercial.

Thesis: Turnaround. Our ML models identify $588K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -33.7% to -26.2% (+747bps).

Net Revenue HCRIS$7.9M
Current EBITDA COMPUTED$-2.7M
Operating Margin COMPUTED-33.7%
Occupancy HCRIS10.2%
Revenue / Bed COMPUTED$232K
Net-to-Gross HCRIS13.5%
Distress Probability ML59.6%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
89
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -33.7% places it below the state median. Among 89 size-comparable peers (17-68 beds), the median margin is -9.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (17-68), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BLACKWELL REGIONAL HOSPITAL (Target)OK34$7.9M-33.7%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
COMMUNITY HOSPITALOK45$143.9M21.7%
INTEGRIS CANADIAN VALLEY HOSPIOK66$84.9M4.6%
OKLAHOMA SPINE HOSPITALOK23$79.0M8.4%
JACKSON COUNTY MEMORIAL HOSPITOK49$75.5M-10.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $588K (747bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$165K+210bp18mo
Denial Rate Reduction12.0%6.5%$160K+203bp12mo
Cost to Collect4.5%2.5%$157K+200bp12mo
A/R Days Reduction5200.0%3800.0%$96K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+12bp6mo

5. EBITDA Bridge

Net Collection Rate
$165K
Denial Rate Reduction
$160K
Cost to Collect
$157K
A/R Days Reduction
$96K
Clean Claim Rate
$10K
Total EBITDA Uplift$588K
Current EBITDA$-2.7M
+ RCM Uplift+$588K
Pro Forma EBITDA$-2.1M
Current Margin-33.7%
Pro Forma Margin-26.2%
WC Released (1x)$302K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.1M$-11.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.1M$-14.1M0.00x-100.0%
Bull Case9.0x11.0x$-3.7M$-13.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.7M$-15.8M0.00x-100.0%
Bear Case11.0x10.0x$-4.5M$-13.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.5M$-16.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 10.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 17-68 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-23.4% / P50=-9.9% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.